サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1465134

エプラジノン市場：適応症、製品、流通チャネル、投与方法別- 世界予測2024-2030年

Eprazinone Market by Indication (Bronchial asthma, Chronic / acute cough, Chronic respiratory failure), Product (Liquid, Tablet), Distribution Channel, Mode of Administation - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 189 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
エプラジノン市場：適応症、製品、流通チャネル、投与方法別- 世界予測2024-2030年
出版日: 2024年04月17日
発行: 360iResearch
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

エプラジノン市場規模は2023年に172億3,000万米ドルと推計され、2024年には186億米ドルに達し、CAGR 8.11%で2030年には297億5,000万米ドルに達すると予測されます。

エプラジノンは、慢性閉塞性肺疾患（COPD）や気管支炎など、粘液の濃縮を特徴とする呼吸器疾患の治療に利用される粘液溶解・去痰薬です。粘液の構造を破壊することにより、気道のクリアランスを容易にし、症状や呼吸機能を改善します。COPD、喘息、気管支炎などの疾患が世界的に急増していることが、エプラジノンの必要性を高めています。エプラジノンの改善されたより効果的な製剤につながる製薬業界における研究開発の高まりは、市場成長の機会を生み出すと期待されています。エプラジノンは、胃腸障害やアレルギーを含む副作用の可能性があるため、特定の人々への使用が制限されています。医薬品承認のための厳しい規制要件が新製剤のイントロダクションを遅らせ、特定地域での市場参入を妨げています。市場ベンダーによるエプラジノンの新製剤の開拓が進むことで、市場成長の機会が生まれると期待されます。

主な市場の統計
基準年[2023］ 172億3,000万米ドル
予測年[2024］ 186億米ドル
予測年 [2030] 297億5,000万米ドル
CAGR（%） 8.11%

適応症気管支喘息の管理におけるエプラジノンのニーズの高まり。

気管支喘息の管理において、エプラジノンは炎症を抑え、気道を弛緩させ、患者の呼吸プロセスを緩和します。エプラジノンは慢性咳嗽、急性咳嗽の治療薬として、咳嗽の頻度や重症度を軽減します。慢性呼吸不全の患者様には、エプラジノンが呼吸機能を改善し、生活の質を高めます。粘液溶解剤として作用するエプラジノンは、排痰プロセスを促進し、様々な呼吸器疾患に関連する咳の管理に効果的なソリューションとなります。慢性・急性気管支炎の去痰作用により、エプラジノンは慢性・急性気管支炎の患者さんにとって欠かせないお薬となり、肺の粘液を取り除きます。インフルエンザの際には、エプラジノンは咳の症状を緩和し、上気道疾患の管理を助けます。エプラジノンは鼻炎の治療にも適応し、鼻づまりやその他の関連症状を緩和し、呼吸を楽にします。

製品エプラジノンの錠剤は、便利で正確な服用が可能なため、嗜好が拡大しています。

液状のエプラジノンは、飲みやすさと速効性を追求した粘液溶解・去痰薬です。錠剤の嚥下が困難な患者さんや、液剤を好む患者さんのために設計されています。この製剤は、特に小児および老年人口に有益です。液状であるため、患者の特定のニーズや重症度に合わせた柔軟な投与が可能です。エプラジノン錠剤は、粘液の過剰分泌を伴う呼吸器疾患の治療に理想的な、便利で正確に投与できる薬剤です。錠剤は、持ち運びが簡単で、保存期間が安定しており、投与量が一定しているため、好まれています。錠剤は成人に処方されることが多く、定期的な投薬スケジュールを守ることができる患者に適しています。エプラジノンの錠剤は、体系的な放出と吸収を促進するように設計されており、持続的な治療効果を保証します。

地域別インサイト

南北アメリカのエプラジノン市場は安定した需要を示しており、その主な要因は、製薬業界の成長と高度なヘルスケアインフラ、呼吸器疾患に対する幅広い認識、大手製薬会社の存在です。南米も市場の成長に寄与しており、ブラジルやメキシコなどの国々がヘルスケア施設を拡大し、医薬品へのアクセスを高めています。規制当局の支援やヘルスケア支出の増加も、南北アメリカにおけるエプラジノンの成長に寄与している要因です。APAC地域では、呼吸器疾患の増加、高齢者人口の増加、医療インフラの改善、中国、インド、日本などにおける可処分所得の増加などがエプラジノン市場の急成長に寄与しています。製薬産業の拡大とヘルスケアに対する政府の有利な政策も、この地域の市場成長を促進する重要な要因です。APAC市場は、研究開発投資の増加とヘルスケア改革に後押しされ、今後数年間で大幅な成長が見込まれます。EMEA地域は、エプラジノンにとって多様な市場環境を示しています。欧州は、確立されたヘルスケアシステム、肺疾患に対する高い意識、呼吸器ケアに注力する大手製薬企業の存在により、強力な市場となっています。中東・アフリカは、欧州に比べ市場規模は小さいもの、ヘルスケアインフラの改善、医療支出の増加、医薬品へのアクセスの増加により成長を遂げています。さらに、医薬品の承認と商業化を支援する規制政策が、EMEAのエプラジノン市場にプラスの影響を与えています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、エプラジノン市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、エプラジノン市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.エプラジノン市場の市場規模および予測は？

2.エプラジノン市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.エプラジノン市場の技術動向と規制枠組みは？

4.エプラジノン市場における主要ベンダーの市場シェアは？

5.エプラジノン市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で呼吸器疾患の罹患率が上昇
      • 投資の増加による医薬品分野の拡大
    • 抑制要因
      • エプラジノンに関連する薬剤の処方の高コスト
    • 機会
      • エプラジノンの新しい処方の開発が進む
      • 規制当局によるエプラジノンの承認増加
    • 課題
      • エプラジノンの利点に関する認識が限られている
  • 市場セグメンテーション分析
    • 適応症：炎症を軽減し気道をリラックスさせる気管支喘息の管理に対するエプラジノンの需要の高まり
    • 製品：エプラジノンタブレットは、薬の投与量を正確に正確に調整できるため、好まれています。
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 エプラジノン市場適応症別

  • 気管支ぜんそく
  • 慢性/急性咳嗽
  • 慢性呼吸不全
  • 咳
  • 慢性/急性気管支炎の去痰薬
  • インフルエンザ
  • 鼻炎

第7章 エプラジノン市場：製品別

  • 液体
  • タブレット

第8章 エプラジノン市場：流通チャネル別

  • 電子商取引プラットフォーム
  • 病院薬局
  • オンライン薬局

第9章 エプラジノン市場投与方法別

  • 静脈内
  • オーラル

第10章 南北アメリカのエプラジノン市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のエプラジノン市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのエプラジノン市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス、2023
  • 競合シナリオ分析
    • バイオシンス、サプライチェーンサービス強化のためヴィオケミカルズを買収
    • アクセラレーテッド・アクセス・コラボレーティブ、脳卒中、心血管疾患、呼吸器疾患のイノベーションに1,100万ユーロの投資を発表
  • 戦略分析と提言

第14章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. EPRAZINONE MARKET RESEARCH PROCESS
  • FIGURE 2. EPRAZINONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EPRAZINONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EPRAZINONE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL EPRAZINONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. EPRAZINONE MARKET DYNAMICS
  • FIGURE 7. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL EPRAZINONE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL EPRAZINONE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EPRAZINONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. EPRAZINONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EPRAZINONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EPRAZINONE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL EPRAZINONE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL EPRAZINONE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL EPRAZINONE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL EPRAZINONE MARKET SIZE, BY BRONCHIAL ASTHMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL EPRAZINONE MARKET SIZE, BY BRONCHIAL ASTHMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL EPRAZINONE MARKET SIZE, BY CHRONIC / ACUTE COUGH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL EPRAZINONE MARKET SIZE, BY CHRONIC / ACUTE COUGH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL EPRAZINONE MARKET SIZE, BY CHRONIC RESPIRATORY FAILURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL EPRAZINONE MARKET SIZE, BY CHRONIC RESPIRATORY FAILURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL EPRAZINONE MARKET SIZE, BY COUGH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL EPRAZINONE MARKET SIZE, BY COUGH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL EPRAZINONE MARKET SIZE, BY EXPECTORANT IN CHRONIC/ACUTE BRONCHITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL EPRAZINONE MARKET SIZE, BY EXPECTORANT IN CHRONIC/ACUTE BRONCHITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL EPRAZINONE MARKET SIZE, BY FLU, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL EPRAZINONE MARKET SIZE, BY FLU, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL EPRAZINONE MARKET SIZE, BY RHINITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL EPRAZINONE MARKET SIZE, BY RHINITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL EPRAZINONE MARKET SIZE, BY LIQUID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL EPRAZINONE MARKET SIZE, BY LIQUID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL EPRAZINONE MARKET SIZE, BY TABLET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL EPRAZINONE MARKET SIZE, BY TABLET, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL EPRAZINONE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL EPRAZINONE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL EPRAZINONE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL EPRAZINONE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL EPRAZINONE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL EPRAZINONE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL EPRAZINONE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL EPRAZINONE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL EPRAZINONE MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL EPRAZINONE MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 79. MEXICO EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 80. MEXICO EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 81. MEXICO EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 82. MEXICO EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 106. AUSTRALIA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 108. AUSTRALIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 110. AUSTRALIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 112. AUSTRALIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 113. CHINA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 114. CHINA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 115. CHINA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 116. CHINA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 117. CHINA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 118. CHINA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 119. CHINA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 120. CHINA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 121. INDIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 122. INDIA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 123. INDIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. INDIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. INDIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. INDIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. INDIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 128. INDIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 129. INDONESIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 130. INDONESIA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 131. INDONESIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. INDONESIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. INDONESIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 134. INDONESIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 135. INDONESIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 136. INDONESIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 137. JAPAN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 138. JAPAN EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 139. JAPAN EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 140. JAPAN EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 141. JAPAN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 142. JAPAN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 143. JAPAN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 144. JAPAN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 145. MALAYSIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 146. MALAYSIA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 147. MALAYSIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. MALAYSIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. MALAYSIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 150. MALAYSIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 151. MALAYSIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 152. MALAYSIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. PHILIPPINES EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. PHILIPPINES EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 158. PHILIPPINES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 160. PHILIPPINES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 161. SINGAPORE EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 162. SINGAPORE EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 163. SINGAPORE EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. SINGAPORE EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. SINGAPORE EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 166. SINGAPORE EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 167. SINGAPORE EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 168. SINGAPORE EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH KOREA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH KOREA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 174. SOUTH KOREA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 176. SOUTH KOREA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 177. TAIWAN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 178. TAIWAN EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 179. TAIWAN EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 180. TAIWAN EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 181. TAIWAN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 182. TAIWAN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 183. TAIWAN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 184. TAIWAN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 185. THAILAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 186. THAILAND EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 187. THAILAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. THAILAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. THAILAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 190. THAILAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 191. THAILAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 192. THAILAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 193. VIETNAM EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 194. VIETNAM EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 195. VIETNAM EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 196. VIETNAM EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 197. VIETNAM EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 198. VIETNAM EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 199. VIETNAM EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 200. VIETNAM EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 211. DENMARK EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 212. DENMARK EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 213. DENMARK EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 214. DENMARK EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 215. DENMARK EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 216. DENMARK EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 217. DENMARK EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 218. DENMARK EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 219. EGYPT EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 220. EGYPT EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 221. EGYPT EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. EGYPT EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. EGYPT EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 224. EGYPT EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 225. EGYPT EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 226. EGYPT EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 227. FINLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 228. FINLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 229. FINLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. FINLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. FINLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 232. FINLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 233. FINLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 234. FINLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 235. FRANCE EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 236. FRANCE EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 237. FRANCE EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. FRANCE EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. FRANCE EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 240. FRANCE EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 241. FRANCE EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 242. FRANCE EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 243. GERMANY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. GERMANY EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. GERMANY EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. GERMANY EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. GERMANY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 248. GERMANY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 249. GERMANY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 250. GERMANY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 251. ISRAEL EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 252. ISRAEL EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 253. ISRAEL EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. ISRAEL EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. ISRAEL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 256. ISRAEL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 257. ISRAEL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 258. ISRAEL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 259. ITALY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 260. ITALY EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 261. ITALY EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. ITALY EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. ITALY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 264. ITALY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 265. ITALY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 266. ITALY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 268. NETHERLANDS EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. NETHERLANDS EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 272. NETHERLANDS EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 274. NETHERLANDS EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 275. NIGERIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 276. NIGERIA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 277. NIGERIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. NIGERIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. NIGERIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 280. NIGERIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 281. NIGERIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 282. NIGERIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 283. NORWAY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 284. NORWAY EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 285. NORWAY EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. NORWAY EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. NORWAY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 288. NORWAY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 289. NORWAY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 290. NORWAY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 291. POLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 292. POLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 293. POLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 294. POLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 295. POLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 296. POLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 297. POLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 298. POLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 299. QATAR EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 300. QATAR EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 301. QATAR EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 302. QATAR EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 303. QATAR EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 304. QATAR EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 305. QATAR EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 306. QATAR EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 307. RUSSIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 308. RUSSIA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 309. RUSSIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 310. RUSSIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 311. RUSSIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 312. RUSSIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 313. RUSSIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 314. RUSSIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 316. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 318. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 320. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 322. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 324. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 326. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 328. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 330. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 331. SPAIN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 332. SPAIN EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 333. SPAIN EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 334. SPAIN EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 335. SPAIN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 336. SPAIN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 337. SPAIN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 338. SPAIN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 339. SWEDEN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 340. SWEDEN EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 341. SWEDEN EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 342. SWEDEN EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 343. SWEDEN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 344. SWEDEN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 345. SWEDEN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 346. SWEDEN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 348. SWITZERLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 350. SWITZERLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 351. SWITZERLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 352. SWITZERLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 353. SWITZERLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 354. SWITZERLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 355. TURKEY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 356. TURKEY EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 357. TURKEY EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 358. TURKEY EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 359. TURKEY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 360. TURKEY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 361. TURKEY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 362. TURKEY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 363. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 364. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 365. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 366. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 367. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 368. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 369. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 370. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 371. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 372. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 373. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)

T

目次
Product Code: MRR-F97DD5A7D578

[189 Pages Report] The Eprazinone Market size was estimated at USD 17.23 billion in 2023 and expected to reach USD 18.60 billion in 2024, at a CAGR 8.11% to reach USD 29.75 billion by 2030.

Eprazinone is a mucolytic and expectorant medication utilized in the treatment of respiratory diseases characterized by thickened mucus, such as chronic obstructive pulmonary disease (COPD) and bronchitis. By breaking down the structure of mucus, it facilitates easier clearance of the airways, improving symptoms and respiratory function. The global surge in conditions, including COPD, asthma, and bronchitis, is driving the need for eprazinone. Rising research and development within the pharmaceutical industry that leads to improved and more effective formulations of eprazinone is expected to create opportunities for market growth. The potential side effects associated with Eprazinone, including gastrointestinal disturbances and allergy risks, limit its use in certain populations. Stringent regulatory requirements for drug approval delay the introduction of new formulations and hinder market entry in certain regions. The growing development of new formulations of eprazinone by market vendors is expected to create opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 17.23 billion
Estimated Year [2024] USD 18.60 billion
Forecast Year [2030] USD 29.75 billion
CAGR (%) 8.11%

Indication: Rising need for eprazinone for the management of bronchial asthma to reduce inflammation and relax the airways

In the management of bronchial asthma, eprazinone helps reduce inflammation and relax the airways, easing the breathing process for patients. Eprazinone serves as a therapeutic agent in relieving both chronic and acute cough, reducing the frequency and severity of cough episodes. For patients experiencing chronic respiratory failure, eprazinone aids in improving respiratory function and enhancing the quality of life. Acting as a mucolytic, eprazinone facilitates the expectoration process, making it an effective solution for managing cough related to various respiratory conditions. Expectorant in chronic/acute bronchitis' expectorant properties make eprazinone an essential medication for patients suffering from both chronic and acute bronchitis, helping to clear mucus from the lungs. During flu episodes, eprazinone can provide symptomatic relief from coughing and assist in the management of upper respiratory tract issues. Eprazinone is also indicated in treating rhinitis, where it helps in alleviating nasal congestion and other related symptoms, facilitating easier breathing.

Product: Expanding preference for eprazinone tablets as they offer a convenient and precisely dosed form of the medication

Liquid eprazinone is a mucolytic and expectorant medication formulated for ease of ingestion and rapid action. It is designed for patients who have difficulty swallowing tablets or have a preference for liquid medication. This formulation is especially beneficial for pediatric and geriatric populations. The liquid form allows for flexible dosing tailored to the specific needs and severity of the patient's condition. Eprazinone tablets offer a convenient and precisely dosed form of the medication, ideal for the treatment of respiratory conditions with excessive mucus production. Tablets are favored for their ease of transport, stable shelf life, and consistent dosing. They are often prescribed to adults and are suited for patients able to adhere to a regular medication schedule. The tablet form of Eprazinone is designed to facilitate systematic release and absorption, ensuring a sustained therapeutic effect.

Regional Insights

The Americas' market for eprazinone has shown consistent demand, mainly driven by the growing pharmaceutical industry and its advanced healthcare infrastructure, widespread awareness of respiratory conditions, and the presence of leading pharmaceutical companies. South America also contributes to the market growth, with countries including Brazil and Mexico expanding their healthcare facilities and increasing accessibility to medications. Regulatory support and the growing healthcare expenditure are other factors contributing to the growth of Eprazinone in the Americas. In the APAC region, the eprazinone market is experiencing rapid growth attributed to the increasing prevalence of respiratory diseases, growing elderly population, improvements in healthcare infrastructure, and rising disposable income in countries such as China, India, and Japan. The expansion of the pharmaceutical industry and favorable government policies toward healthcare are also significant factors driving market growth in this region. The APAC market is expected to witness substantial growth in the coming years, fueled by increased investment in R&D and healthcare reforms. The EMEA region presents a diverse market landscape for Eprazinone. Europe is a strong market due to its well-established healthcare systems, high awareness regarding pulmonary diseases, and the presence of major pharmaceutical companies focusing on respiratory care. The Middle East and Africa, though smaller markets compared to Europe, are witnessing growth due to improving healthcare infrastructure, rising healthcare spending, and increasing access to medications. Moreover, regulatory policies supporting drug approval and commercialization are positively impacting the Eprazinone market in EMEA.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Eprazinone Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Eprazinone Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Eprazinone Market, highlighting leading vendors and their innovative profiles. These include BenchChem, Biosynth Ltd, BOC Sciences, Clearsynth, HK Starshine Printing Design Co., Ltd., J&H CHEM Co., Ltd., MedicaPharma BV, MuseChem Chemicals, Nordic Biosite, Procurenet Limited, R.R Scientific, LLC, RayBiotech, Inc., and VIVAN Life Sciences.

Market Segmentation & Coverage

This research report categorizes the Eprazinone Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Bronchial asthma
    • Chronic / acute cough
    • Chronic respiratory failure
    • Cough
    • Expectorant in chronic/acute bronchitis
    • Flu
    • Rhinitis
  • Product
    • Liquid
    • Tablet
  • Distribution Channel
    • eCommerce Platforms
    • Hospital Pharmacies
    • Online Pharmacies
  • Mode of Administation
    • Intravenous
    • Oral
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Eprazinone Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Eprazinone Market?

3. What are the technology trends and regulatory frameworks in the Eprazinone Market?

4. What is the market share of the leading vendors in the Eprazinone Market?

5. Which modes and strategic moves are suitable for entering the Eprazinone Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of respiratory diseases worldwide
      • 5.1.1.2. Expanding the pharmaceutical sector with increasing investments
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of formulations of medications associated with eprazinone
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing development of new formulations of eprazinone
      • 5.1.3.2. Rising approvals for eprazinone by regulatory authorities
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness associated with the benefits of eprazinone
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: Rising need for eprazinone for the management of bronchial asthma to reduce inflammation and relax the airways
    • 5.2.2. Product: Expanding preference for eprazinone tablets as they offer a convenient and precisely dosed form of the medication
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Eprazinone Market, by Indication

  • 6.1. Introduction
  • 6.2. Bronchial asthma
  • 6.3. Chronic / acute cough
  • 6.4. Chronic respiratory failure
  • 6.5. Cough
  • 6.6. Expectorant in chronic/acute bronchitis
  • 6.7. Flu
  • 6.8. Rhinitis

7. Eprazinone Market, by Product

  • 7.1. Introduction
  • 7.2. Liquid
  • 7.3. Tablet

8. Eprazinone Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. eCommerce Platforms
  • 8.3. Hospital Pharmacies
  • 8.4. Online Pharmacies

9. Eprazinone Market, by Mode of Administation

  • 9.1. Introduction
  • 9.2. Intravenous
  • 9.3. Oral

10. Americas Eprazinone Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Eprazinone Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Eprazinone Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Biosynth acquires Vio Chemicals to Fortify its Supply Chain Services
    • 13.3.2. Accelerated Access Collaborative announces Euro 11 million investment in stroke, cardiovascular disease and respiratory innovations
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio